FREE Equity Delivery and MF
Flat ₹20/trade Intra-day/F&O
|
Comparision between Nidan Laboratories and Healthcare IPO and Suyog Gurbaxani Funicular Ropeways IPO.
Nidan Laboratories and Healthcare IPO is a SME Fixed Price Issue IPO proposed to list at NSE SME while Suyog Gurbaxani Funicular Ropeways IPO is a SME Fixed Price Issue proposed to list at BSE SME.
Nidan Laboratories and Healthcare IPO | Suyog Gurbaxani Funicular Ropeways IPO | |
---|---|---|
Logo | ||
Issue Category | SME | SME |
Issue Type | IPO | IPO |
Process Type | Fixed Price Issue | Fixed Price Issue |
Listing At | NSE SME | BSE SME |
Lead Managers | First Overseas Capital Limited | Aryaman Financial Services Limited |
Registrar | Bigshare Services Pvt Ltd | Kfin Technologies Limited |
Market Maker | ||
DRHP | DRHP | DRHP |
RHP | RHP | RHP |
Anchor Investor | ||
IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Nidan Laboratories and Healthcare IPO is up to ₹50.00 Cr whereas the issue size of the Suyog Gurbaxani Funicular Ropeways IPO is up to ₹29.50 Cr. The final issue price of Nidan Laboratories and Healthcare IPO is ₹125.00 per share and of Suyog Gurbaxani Funicular Ropeways IPO is ₹45.00 per share.
Nidan Laboratories and Healthcare IPO | Suyog Gurbaxani Funicular Ropeways IPO | |
---|---|---|
Face Value | ₹10 per share | ₹10 per share |
Issue Price (Lower) | ||
Issue Price (Upper) | ||
Issue Price (Final) | ₹125.00 per share | ₹45.00 per share |
Discount (Retail) | ||
Discount (Employee) | ||
Market Lot Size | 1000 shares | 3000 shares |
Fresh Issue Size | 15,00,000 shares | |
Fresh Issue Size (Amount) | up to ₹6.75 Cr | |
OFS Issue Size | 50,55,000 shares | |
OFS Issue Size (Amount) | up to ₹22.75 Cr | |
Issue Size Total | 40,00,000 shares | 65,55,000 shares |
Issue Size Total (Amount) | up to ₹50.00 Cr | up to ₹29.50 Cr |
Nidan Laboratories and Healthcare IPO opens on Oct 28, 2021, while Suyog Gurbaxani Funicular Ropeways IPO opens on Nov 01, 2021. The closing date of Nidan Laboratories and Healthcare IPO and Suyog Gurbaxani Funicular Ropeways IPO is Nov 02, 2021, and Nov 08, 2021, respectively.
Nidan Laboratories and Healthcare IPO | Suyog Gurbaxani Funicular Ropeways IPO | |
---|---|---|
Anchor Bid Date | ||
Issue Open | Oct 28, 2021 | Nov 01, 2021 |
Issue Close | Nov 02, 2021 | Nov 08, 2021 |
Basis Of Allotment (Tentative) | Nov 09, 2021 | Nov 11, 2021 |
Initiation of Refunds (Tentative) | Nov 10, 2021 | Nov 12, 2021 |
Credit of Share (Tentative) | Nov 11, 2021 | Nov 15, 2021 |
Listing date (Tentative) | Nov 12, 2021 | Nov 16, 2021 |
Anchor Lockin End date 1 | Dec 09, 2021 | Dec 11, 2021 |
Anchor Lockin End date 2 | Feb 07, 2022 | Feb 09, 2022 |
Nidan Laboratories and Healthcare IPO P/E ratio is , as compared to Suyog Gurbaxani Funicular Ropeways IPO P/E ratio of .
Nidan Laboratories and Healthcare IPO | Suyog Gurbaxani Funicular Ropeways IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Financial |
|
|
||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Pre-Issue) | 99.99% | 90.57% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Promoter Shareholding (Post-Issue) | 71.22% | 64.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||
P/E Ratio | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Market Cap | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
ROCE | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Debt/Equity | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
EPS | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
RoNW |
In the Nidan Laboratories and Healthcare IPO retail investors (RII) are offered 19,00,000 shares while in Suyog Gurbaxani Funicular Ropeways IPO retail investors are offered 19,00,000 shares. Qualified institutional buyers (QIB) are offered in Nidan Laboratories and Healthcare IPO and in Suyog Gurbaxani Funicular Ropeways IPO.
Nidan Laboratories and Healthcare IPO | Suyog Gurbaxani Funicular Ropeways IPO | |
---|---|---|
Anchor Investor Reserveration | ||
Market Maker Reserveration | 2,00,000 shares | 3,33,000 shares |
QIB | ||
NII | 19,00,000 shares | 31,11,000 shares |
RII | 19,00,000 shares | 31,11,000 shares |
Employee | ||
Others | ||
Total | 38,00,000 shares | 62,22,000 shares |
Nidan Laboratories and Healthcare IPO subscribed 1.80x in total, whereas Suyog Gurbaxani Funicular Ropeways IPO subscribed 1.27x.
Nidan Laboratories and Healthcare IPO | Suyog Gurbaxani Funicular Ropeways IPO | |
---|---|---|
QIB (times) | ||
NII (times) | 0.15x | 1.98x |
Big NII (times) | ||
Small NII (times) | ||
RII (times) | 3.44x | 0.56x |
Employee (times) | ||
Other (times) | ||
Total (times) | 1.80x | 1.27x |
Add a public comment...
FREE Intraday Trading (Eq, F&O)
Flat ₹20 Per Trade in F&O
|